UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Nature communications, 2021-02, Vol.12 (1), p.868-868, Article 868

2021

Volltextzugriff (PDF)

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

The New England journal of medicine, 2021-02, Vol.384 (8), p.705-716

2021

Volltextzugriff (PDF)

Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy

Cancers, 2017-07, Vol.9 (7), p.92

2017

Volltextzugriff (PDF)

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

The New England journal of medicine, 2019-05, Vol.380 (18), p.1726-1737

2019

Volltextzugriff (PDF)

Promise and Challenge of RNA Interference–Based Therapy for Cancer

Journal of clinical oncology, 2011-02, Vol.29 (6), p.747-754

2011

Volltextzugriff (PDF)

Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival

Molecular cancer therapeutics, 2017-12, Vol.16 (12), p.2849-2861

2017

Volltextzugriff (PDF)

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

JAMA : the journal of the American Medical Association, 2007-05, Vol.297 (17), p.1901

2007

Volltextzugriff (PDF)

MicroRNA signatures in human ovarian cancer

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (18), p.8699-8707

2007

Volltextzugriff (PDF)

A MicroRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (7), p.2257-2261

2006

Volltextzugriff (PDF)

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

PloS one, 2009-09, Vol.4 (9), p.e7181

2009

Volltextzugriff (PDF)

A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells

Cancer cell, 2013-08, Vol.24 (2), p.182-196

2013

Volltextzugriff (PDF)

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6162-6170

2008

Volltextzugriff (PDF)

Abstract 420: Preclinical evaluation of the SF3B1 inhibitor E7107 in triple negative breast cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.420-420

2017

Volltextzugriff (PDF)

Abstract 74: Targeting nuclear export for triple-negative breast cancer therapy

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.74-74

Petrocca, Fabio

2016

Volltextzugriff (PDF)

Micromanipulating cancer: microRNA-based therapeutics?

RNA biology, 2009-07, Vol.6 (3), p.335-340

2009

Volltextzugriff (PDF)

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

Cancer research (Chicago, Ill.), 2008-10, Vol.68 (20), p.8191-8194

2008

Volltextzugriff (PDF)

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Blood, 2023-11, Vol.142 (Supplement 1), p.7432-7432

2023

Volltextzugriff (PDF)

Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

Nature medicine, 2023-09, Vol.29 (9), p.2286-2294

2023

Volltextzugriff (PDF)

E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer

Cancer cell, 2008-03, Vol.13 (3), p.272-286

2008

Volltextzugriff (PDF)

Abstract 4469: Targeting the tri-snRNP complex for triple-negative breast cancer therapy

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4469-4469

2017

Volltextzugriff (PDF)

Pre-Clinical Evaluation of Combined Proteasome and Spliceosome Inhibition in Triple Negative Breast Cancer (TNBC)

Journal of the American College of Surgeons, 2017-10, Vol.225 (4), p.e61-e61

2017

Volltextzugriff (PDF)

Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells

Molecular cancer therapeutics, 2015-10, Vol.14 (10), p.2279-2291

2015

Volltextzugriff (PDF)

Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma

Blood, 2020-11, Vol.136 (Supplement 1), p.14-14

2020

Volltextzugriff (PDF)

Micro-RNAs in Gastrointestinal and Liver Disease

Gastroenterology (New York, N.Y. 1943), 2008-12, Vol.135 (6), p.1866-1869

2008

Volltextzugriff (PDF)

RIG-ing an antitumor response

Nature medicine, 2008-11, Vol.14 (11), p.1152-1153

2008

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(48)
Buchkapitel
(1)

Sprache

Englisch
(49)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

11 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Promise and Challenge of RNA Interference–Based Therapy for Cancer

Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

MicroRNA signatures in human ovarian cancer

A MicroRNA Expression Signature of Human Solid Tumors Defines Cancer Gene Targets

miR-200 enhances mouse breast cancer cell colonization to form distant metastases

A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer

Abstract 420: Preclinical evaluation of the SF3B1 inhibitor E7107 in triple negative breast cancer

Abstract 74: Targeting nuclear export for triple-negative breast cancer therapy

Micromanipulating cancer: microRNA-based therapeutics?

Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling

When a Number Is Just a Number: Duffy-Null Blood Group Phenotype, Absolute Neutrophil Count, and Incidence of Neutropenic Fever and Chemotherapy Dose Reductions in Patients Treated for Plasma Cell Dyscrasias

Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial

E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer

Abstract 4469: Targeting the tri-snRNP complex for triple-negative breast cancer therapy

Pre-Clinical Evaluation of Combined Proteasome and Spliceosome Inhibition in Triple Negative Breast Cancer (TNBC)

Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells

Biallelic Loss of BCMA Triggers Resistance to Anti-BCMA CAR T Cell Therapy in Multiple Myeloma

Micro-RNAs in Gastrointestinal and Liver Disease

RIG-ing an antitumor response

Suchergebnisse filtern